We are live on ! Find out more
AH

Aviva Holdings Portfolio holdings

AUM $20.5M
1-Year Est. Return 117.01%
This Fund
S&P 500
This Quarter Est. Return
-17.48%
1 Year Est. Return
+117.01%
3 Year Est. Return
-36.54%
5 Year Est. Return
-22.08%
10 Year Est. Return
AUM
$159M
AUM Growth
-$55.9M
Cap. Flow
-$15.7M
Cap. Flow %
-9.89%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$15.7M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDCO
1
DELISTED
Medicines Co
MDCO
$132M 83.45%
3,481,599
-352,300
-9% -$15.7M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$15.7M 9.92%
340,000
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$10.5M 6.63%
2,880,702

Similar funds

Aviva Holdings's Q2 2017 Portfolio in Review

As of Q2 2017, Aviva Holdings held 3 positions worth $159M, down 26% from $214M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Aviva Holdings withdrew a net $15.7M in Q2 2017, reducing 1 holding. Its largest reduction was Medicines Co, cutting an estimated $15.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Aviva Holdings's biggest Q2 2017 reduction was Medicines Co, cutting an estimated $15.7M.
  • Aviva Holdings's ten largest holdings make up 100% of its $159M portfolio in Q2 2017.
  • Aviva Holdings opened 0 new positions and closed 0 in Q2 2017.
  • Aviva Holdings's portfolio value fell 26% quarter-over-quarter to $159M.

Based on Aviva Holdings's 13F filing for Q2 2017, filed 14 Aug 2017.